Research & Innovation
Our innovation strategy
Our innovation strategy is focused on improving the quality of life of patients. The “healthcare solution” concept includes the idea of comprehensive care. This leads to the formulation of products that are effective for the patient, but also consideration for the patient’s environment throughout the course of care. Product development can be combined with diagnostic tools, services or digital solutions for better patient support.
Our fields of research
New usages of proven molecules
e.g. mannitol, glycyrrhizin
Selection of nutrients intended for targeted medical use
e.g. PEA, citicoline
Mastery of interactions in formula composition
e.g. microencapsulation
Bioavailability of molecules
e.g. 5-MTHF*, iron bisglycinate, triglycerides
*5-methyltetrahydrofolate
Galenic innovation or optimisation of existing forms
e.g. Suvéal Duo™ at 1 capsule/day
Development of formulae without controversial substances
e.g. preservative-free eye drops, non-hormonal alternative
Densmore Company is a member of Ophta Biotech, an entity in the Eurobiomed competitiveness cluster. The association brings together private and public actors from the world of ophthalmology: manufacturers, researchers, universities and patient associations. The goal is to achieve projects that serve visually-impaired populations.
